BONNIE STALLINGS: Open Payments
NPI 1215467782 · FLINT, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,683 in 162 payments from 50 companies in 2025. Trend: 2023 $102 · 2024 $2,735 · 2025 $4,683
Food & beverage: $3,267Long term medical supply or device loan: $964Education: $541
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 22 | $1,151 |
| Janssen Biotech, Inc. | 23 | $449 |
| ABBVIE INC. | 10 | $323 |
| Incyte Corporation | 4 | $149 |
| Merck Sharp & Dohme LLC | 7 | $144 |
| Astellas Pharma US Inc | 2 | $123 |
| Daiichi Sankyo Inc. | 5 | $115 |
| Janssen Scientific Affairs, LLC | 3 | $107 |
| SANOFI-AVENTIS U.S. LLC | 1 | $100 |
| Genentech USA, Inc. | 4 | $94 |
Products named: KISQALI, VENCLEXTA, RYBREVANT, ERLEADA, SARCLISA, KEYTRUDA, DARZALEX, EPKINLY.
Industry payments across MI — which companies pay providers there.
